ANDOVER,
Mass. , Dec. 23,
2024 /PRNewswire/ -- TransMedics Group, Inc.
("TransMedics") (Nasdaq: TMDX), a medical technology company that
is transforming organ transplant therapy for patients with
end-stage lung, heart, and liver failure, today announced that
members of the management team will present at the upcoming
43rd Annual J.P. Morgan Healthcare Conference. The
presentation will take place on Monday,
January 13, 2025, at 2:15 p.m.
Pacific Standard Time / 5:15 p.m.
Eastern Standard Time.
Event: 43rd Annual J.P. Morgan Healthcare
Conference
Date: Monday, January 13,
2025
Time: 2:15 p.m. PST
A live and archived webcast of the presentation will be
available on the "Investors" section of the TransMedics website at
https://investors.transmedics.com/. The Company's standard investor
presentation is also available through this link.
About TransMedics Group, Inc.
TransMedics is the
world's leader in portable extracorporeal warm perfusion and
assessment of donor organs for transplantation. Headquartered in
Andover, Massachusetts, the
company was founded to address the unmet need for more and better
organs for transplantation and has developed technologies to
preserve organ quality, assess organ viability prior to transplant,
and potentially increase the utilization of donor organs for the
treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian
Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302338418.html
SOURCE TransMedics Group, Inc.